<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05109130</url>
  </required_header>
  <id_info>
    <org_study_id>GIHSYSU-20</org_study_id>
    <nct_id>NCT05109130</nct_id>
  </id_info>
  <brief_title>Change of Circulating Tumor Cells Quantity in the Central Vein During Laparoscopic or Transanal Endoscopic Surgery for Rectal Cancer.</brief_title>
  <official_title>Sixth Affiliated Hospital, Sun Yat-sen University</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to compare the changes of circulating tumor cells (CTCs)&#xD;
      at different time points in rectal cancer patients undergoing laparoscopic or transanal&#xD;
      endoscopic radical resection. Our secondary purpose is to explore the effects of&#xD;
      perioperative circulating tumor cells on tumor recurrence and metastasis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mid-low rectal cancer is one of the common malignant tumors and the incidence has increased&#xD;
      significantly in recent years. At present, surgery is still the most important and effective&#xD;
      method for the treatment of mid-low rectal cancer. Traditional laparoscopic surgery and&#xD;
      emerging transanal total mesorectal excision (TaTME) are the main methods. More than&#xD;
      one-third of rectal cancer patients will eventually local recurrence and distant metastasis,&#xD;
      which are the most important factors affecting prognosis. Circulating tumor cells may lead to&#xD;
      distant metastasis, so the detection of CTCs in blood has important clinical significance in&#xD;
      predicting recurrence and metastasis of rectal cancer and monitoring treatment response. Due&#xD;
      to the different degrees of contact between distinct surgical methods, this may lead to an&#xD;
      increase in the quantity of CTCs in the blood, which may affect the prognosis of patients.&#xD;
      Therefore, the investigators conducted a randomized controlled study to compare the changes&#xD;
      in the quantity of CTCs in the central vein before, during and after operation in rectal&#xD;
      cancer patients undergoing transanal endoscopic or laparoscopic radical resection. To explore&#xD;
      the effect of two surgical methods on the risk of micrometastasis, and to provide new ideas&#xD;
      for the selection and improvement of rectal cancer treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 18, 2021</start_date>
  <completion_date type="Anticipated">October 2025</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of circulating tumor cells during laparoscopic or transanal endoscopic surgery</measure>
    <time_frame>1 years</time_frame>
    <description>Determine the changes of circulating tumor cells at different time points in patients undergoing laparoscopic or transanal endoscopic radical resection of rectal cancer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease free survival</measure>
    <time_frame>3 years</time_frame>
    <description>Determine relationship of CTC numbers and local recurrence and distant metastasis</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Rectal Neoplasms</condition>
  <condition>Neoplastic Cells, Circulating</condition>
  <condition>Laparoscopic Surgery</condition>
  <condition>Transanal Endoscopic Surgery</condition>
  <arm_group>
    <arm_group_label>laparoscopic surgery</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Transanal endoscopic surgery</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical approach</intervention_name>
    <description>Different surgical methods for rectal cancer resection</description>
    <arm_group_label>Transanal endoscopic surgery</arm_group_label>
    <arm_group_label>laparoscopic surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        100 rectal cancer patients will be enrolled. Patients must be older than 18 years.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Mid-low rectal cancer.&#xD;
&#xD;
          2. Single lesion.&#xD;
&#xD;
          3. No metastasis.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. History of malignant tumors.&#xD;
&#xD;
          2. Acute bowel obstruction, bleeding or perforation.&#xD;
&#xD;
          3. Tumor over 6cm in diameter or in severe adhesion with surrounded tissues.&#xD;
&#xD;
          4. Severe other contradictions of surgery.&#xD;
&#xD;
          5. Pregnant women will be excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of colorectal surgery, the Sixth Affiliated Hospital, Sun Yat-Sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510655</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 26, 2021</study_first_submitted>
  <study_first_submitted_qc>October 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2021</study_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Yanhong Deng</investigator_full_name>
    <investigator_title>Sun Yat-sen University</investigator_title>
  </responsible_party>
  <keyword>rectal cancer</keyword>
  <keyword>CTCs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
    <mesh_term>Neoplastic Cells, Circulating</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

